Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
DIH Holding US, Inc. is a publicly traded medical technology company that develops, manufactures, and commercializes diagnostic and rehabilitation solutions primarily for cardiovascular, pulmonary, and physical therapy applications. The company operates within the medical devices and healthcare technology industries, focusing on clinical assessment, rehabilitation, and performance monitoring across the continuum of care. Its solutions are used by hospitals, outpatient clinics, rehabilitation centers, and sports performance facilities.
The company’s primary revenue drivers are hardware systems, recurring software licenses, and service contracts associated with diagnostic testing and rehabilitation platforms. DIH Holding is positioned as an integrated provider combining data-driven diagnostics with therapy solutions, differentiating itself through clinically validated technologies and a portfolio that spans evaluation through recovery. The company was formed through the merger of several established healthcare technology businesses and completed a public listing via a special purpose acquisition company transaction in 2022, consolidating complementary brands under a single operating structure.
Business Operations
DIH Holding conducts operations through distinct but integrated business segments centered on diagnostics, rehabilitation, and software-enabled clinical workflow. Key operating subsidiaries include DIH Medical, AlterG, Humac Norm, PhysioChattanooga, and 3DT Holdings, each contributing specialized technologies such as anti-gravity treadmills, isokinetic testing systems, cardiac diagnostics, and rehabilitation equipment. Revenue is generated through equipment sales, subscription-based software, consumables, and long-term service and maintenance agreements.
The company operates in both domestic and international markets, with sales channels that include direct sales teams, distributors, and strategic partners. Its technology portfolio includes FDA-cleared medical devices, proprietary hardware systems, and cloud-enabled software platforms designed to support clinical decision-making and patient outcome tracking. DIH Holding maintains manufacturing, assembly, and research and development capabilities while leveraging third-party suppliers for certain components.
Strategic Position & Investments
DIH Holding’s strategic direction emphasizes expanding its integrated ecosystem of diagnostics and rehabilitation solutions while increasing recurring revenue from software and services. Growth initiatives include cross-selling across its installed customer base, enhancing data analytics capabilities, and expanding use cases beyond traditional clinical settings into sports science, military, and occupational health markets.
The company’s strategy has been shaped by prior acquisitions that formed its current portfolio, including the integration of AlterG and DIH Medical, which broadened its exposure to rehabilitation and cardiovascular diagnostics. DIH Holding continues to invest in digital health, connected devices, and outcome-focused technologies to strengthen its competitive position and support value-based care models. Public disclosures indicate a focus on disciplined capital allocation rather than speculative investment activity.
Geographic Footprint
DIH Holding is headquartered in the United States and maintains a significant presence across North America, which represents its largest revenue-generating region. The company also operates in Europe, Asia-Pacific, and Latin America, serving customers in more than 60 countries through a combination of direct operations and distributor networks.
International operations support both sales and service functions, and certain subsidiaries maintain localized manufacturing or assembly capabilities. The company’s global footprint allows it to participate in developed and emerging healthcare markets, with international revenue providing diversification beyond the U.S. healthcare system.
Leadership & Governance
DIH Holding is led by an executive team with experience across medical devices, healthcare services, and public company management. The leadership emphasizes operational integration, clinical validation, and long-term value creation through technology-driven healthcare solutions.
Key executives include:
- Zvi Ben-Rafael – Chief Executive Officer
- Gerald McMahon – Chief Financial Officer
- Richard McConnell – Chief Operating Officer
- Jeff R. Johnson – Chief Commercial Officer
- Ken Rechter – President, Diagnostics
The company is governed by a board of directors responsible for strategic oversight, risk management, and regulatory compliance, consistent with U.S. public company standards and disclosure requirements.